Skip to main content
Navamedic logo

Navamedic — Investor Relations & Filings

Ticker · NAVA ISIN · NO0010205966 LEI · 529900LKVQOR2SRUJU71 OL Wholesale and retail trade
Open in API
Filings indexed 825 across all filing types
Latest filing 2022-05-31 Share Issue/Capital Cha…
Country NO Norway
Listing OL NAVA

About Navamedic

https://navamedic.com/

Navamedic is a pharmaceutical company that develops, produces, and commercializes a diverse portfolio of medicines and related health products. The company's offerings include specialty pharmaceuticals, branded generics, and consumer health items. Its product portfolio addresses various medical needs, with treatments for conditions such as obesity, Parkinson's disorder, and inborn errors of metabolism, in addition to antibiotics. Serving as a reliable supplier and distribution partner, Navamedic provides high-quality products to hospitals and pharmacies, with a strong presence in the Nordic region and the Netherlands. The company focuses on improving patient outcomes through innovations, including advancements in personalized treatment for Parkinson's care.

Recent filings

Filing Released Lang Actions
NAVAMEDIC ASA: RESOLUTION TO INCREASE THE SHARE CAPITAL IN CONNECTION WITH EXERCISE OF EMPLOYEE OPTIONS
Share Issue/Capital Change Classification · 98% confidence The document explicitly announces a 'RESOLUTION TO INCREASE THE SHARE CAPITAL IN CONNECTION WITH EXERCISE OF EMPLOYEE OPTIONS'. It details the issuance of new shares (75,000 new shares) to settle exercised share options, resulting in a change to the total share capital. This action directly relates to changes in the company's capital structure and share count. Based on the definitions, the 'Share Issue/Capital Change' (SHA) category is the most appropriate fit, as it covers announcements regarding new share issues or capital structure changes.
2022-05-31 English
Navamedic ASA: Notice of Annual General Meeting
AGM Information Classification · 100% confidence The document text explicitly contains the heading "INNKALLING TIL ORDINÆR GENERALFORSAMLING" (Norwegian) and "NOTICE OF ANNUAL GENERAL MEETING" (English). It details the date (2. juni 2022), time, location, and the agenda items for the meeting, such as election of chair, approval of the annual accounts, and board elections. This content is characteristic of a formal notice sent out prior to an Annual General Meeting (AGM). Therefore, the correct classification is AGM-R.
2022-05-12 Norwegian
Navamedic ASA: Notice of Annual General Meeting
Report Publication Announcement Classification · 99% confidence The document explicitly states it is a 'Notice of Annual General Meeting' for Navamedic ASA and mentions the date and location of the AGM. It also states that the 'Notice of the Annual General Meeting is attached' and available online. This content directly relates to the upcoming Annual General Meeting proceedings, fitting the definition for AGM Information (AGM-R). Although it is a notice, the content is specific to the AGM event itself, making AGM-R a better fit than the general RPA or RNS fallback, especially given the short length suggesting it's the notice document rather than the full presentation.
2022-05-12 English
Navamedic ASA: Resultater for første kvartal 2022
Investor Presentation Classification · 99% confidence The document explicitly states it covers the "Q1 2022 First quarter results 2022" and presents detailed financial tables for Q1 2022 compared to Q1 2021, including Profit and Loss statements and Balance Sheets (Assets/Liabilities as of 31.03.2022). This structure and content are characteristic of a comprehensive financial report covering a period shorter than a full year. This aligns perfectly with the definition of an Interim / Quarterly Report (IR). It is not an Earnings Release (ER) because it contains full financial statements, not just highlights, and it is not a 10-K as it is only for Q1.
2022-05-10 English
Navamedic ASA: Resultater for første kvartal 2022
Earnings Release Classification · 100% confidence The document is titled "Navamedic ASA: Resultater for første kvartal 2022" (Results for the first quarter 2022) and contains key financial metrics (revenue, EBITDA, gross margin) and management commentary specific to the first quarter of 2022. This clearly indicates it is a report detailing financial performance for a period shorter than a year. The document also mentions an upcoming presentation of these results, but the text provided is the summary of the results themselves, not just the announcement of the presentation. Therefore, it fits the definition of an Interim / Quarterly Report (IR). The document length (4448 chars) is substantial enough to be the report summary rather than just a brief RPA. Q1 2022
2022-05-10 Norwegian
Navamedic ASA: Invitation to 2022 first quarter presentation
Earnings Release Classification · 95% confidence The document is titled "Navamedic ASA: Invitation to 2022 first quarter presentation" and explicitly states that the company "will be presenting its first quarter 2022 results on Tuesday, May 10th." It provides details about the time, location, and a link to the live webcast for this presentation. This is an announcement inviting stakeholders to an event where quarterly results will be discussed, which strongly suggests it is related to an Earnings Release (ER) or an Investor Presentation (IP). Since it is an invitation to the presentation of the results, and not the results document itself, it functions as a notification about an upcoming event where financial performance will be discussed. Given the context of quarterly results, it is most closely aligned with an Earnings Release (ER) announcement, or potentially an Investor Presentation (IP) if the presentation material is the focus. However, the primary purpose here is announcing the presentation of the Q1 results. Since the document is very short (1295 chars) and is an invitation/notice about the presentation of results, it fits the pattern of an announcement rather than the full report. If the results themselves were attached, it might be RPA, but this is an invitation to the event. Given the focus on the 'first quarter presentation,' it is best classified as an announcement related to the earnings event, which often precedes or accompanies the formal ER. I will classify this as an Earnings Release (ER) announcement, as the presentation is about the Q1 results. Q1 2022
2022-05-09 English

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.